Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 466696015 | Irinotecan hydrochloride trihydrate 100mg/5mL infusion concentrate | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 1457174013 | Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 5mL vial (product) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 1477702016 | Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 5mL vial | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 5mL vial | Is a | Irinotecan hydrochloride | false | Inferred relationship | Some | ||
| Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 5mL vial | Is a | Product containing irinotecan (medicinal product) | false | Inferred relationship | Some | ||
| Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 5mL vial | Is a | Irinotecan hydrochloride | false | Inferred relationship | Some | ||
| Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 5mL vial | Has active ingredient | Irinotecan hydrochloride (substance) | false | Inferred relationship | Some | ||
| Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 5mL vial | Has manufactured dose form | Injection | false | Inferred relationship | Some | ||
| Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 5mL vial | Has active ingredient | Irinotecan (substance) | false | Inferred relationship | Some | ||
| Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 5mL vial | Has active ingredient | Irinotecan hydrochloride (substance) | false | Inferred relationship | Some | ||
| Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 5mL vial | Is a | Product manufactured as parenteral dose form (product) | false | Inferred relationship | Some | ||
| Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 5mL vial | Has manufactured dose form | Infusion concentrate | false | Inferred relationship | Some | ||
| Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 5mL vial | Is a | Product containing irinotecan in parenteral dose form (medicinal product form) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Camptosar 20mg/ml injection 5mL vial | Is a | False | Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 5mL vial | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)
FHIR